Advancing intermittent catheter technology - 'A path to better patient outcomes'

At this year’s Infection Prevention & Control conference, a compelling and well-received session addressed some of the most pressing challenges in urological care: reducing catheter-associated complications, enhancing the patient experience in intermittent self-catheterisation (ISC) and introducing a unique new technology regarding catheter lubrication. The session, introduced by Sue Thoms, brought together leading voices in nursing and clinical research to discuss the latest evidence, technologies, and holistic approaches to improving outcomes for ISC users.
 

Understanding the risks and strategic response

Nurse Sarah Stockwell opened the discussion with a comprehensive overview of the risks associated with catheterisation, focusing on catheter-associated urinary tract infections (CAUTI) and the potentially life-threatening complication of urosepsis. The clinical concerns were contextualised within the broader public health framework, highlighting the government’s antimicrobial resistance strategy. She emphasised the need for evidence-based interventions that reduce infection risk while preserving patient independence and quality of life.

A historical perspective and a technological leap forward

Laura Corner followed with a historical overview of ISC, tracing its evolution from early innovations to the present day. She introduced the audience to Convatec’s FeelClean Technology, detailing how this innovation represents a significant leap forward in reducing friction, maintaining catheter integrity, and improving comfort during insertion and removal. The technology’s design aims to support both safety and adherence, addressing some of the long-standing concerns voiced by clinicians and patients alike.

Clinical evidence supporting FeelClean

Dave Pollard presented the latest evidence underpinning FeelClean technology, including compelling data from recent studies using a porcine urethra model. These studies demonstrated the material’s low friction coefficient and superior performance in maintaining urethral health, reinforcing its potential to reduce trauma and associated infections. This presentation bridged the gap between laboratory findings and real-world clinical impact, underscoring the importance of innovation driven by robust research.
 

Reframing patient care in the community

Closing the session, Sue Thoms returned to the stage to address the critical role of primary care in the long-term management of ISC users. She advocated for structured ISC patient reviews in community settings, which are essential not only for monitoring clinical outcomes but also for supporting adherence and detecting early signs of complications. She also introduced the Convatec Emotional and Psychological Wellbeing Programme, a novel initiative designed to provide holistic support for ISC users, recognising the mental and emotional toll that long-term catheter use can have on patients.